ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy

Liang, Jinxiu; Hao, Wenke; Xia, Fangxiao; Zhao, Zhi; Wu, Yanhua; Yu, Feng; Hu, Wenxue; Fang, Xiaowu; Liu, Wei*广东省人民医院; 南方医科大学
RENAL FAILURE2023-12-31DOI: 10.1080/0886022X.2023.2212081
1被引18阅读
引用收藏
分享

摘要

Background Idiopathic membranous nephropathy (IMN) is the leading cause of nephrotic syndrome in the elderly. The treatment of idiopathic membranous nephropathy is quite challenging due to the particularity of elderly patients. This study intends to investigate the clinicopathological characteristics and initial therapeutic effect of idiopathic membranous nephropathy among elderly patients. Methods A retrospective study of 67 elderly patients (58.2% male, median age 69.0 years, range, 65-83 years) with biopsy-proven membranous nephropathy was conducted at Guangdong Provincial People's Hospital from 2016 to 2020. Data on clinicopathological characteristics and initial therapeutic effects were analyzed. Results Of the 67 patients, the mean eGFR of overall patients was 66.49 mL/min/1.73m(2) while the median urine protein-to-creatinine ratio (uPCR) and urine albumin-to-creatinine ratio (uACR) was 5676.73 mg/g and 2951.56 mg/g, respectively. Pathological data revealed that the membranous Churg's stage II was the most frequent (71.64%). Moreover, glomerular PLA2R antigen fluorescence intensity of (+) and IgG4 antigen fluorescence intensity of (++) were detected in 63.6% and 86.4% of all patients, respectively. Overall, 44 patients, accounting for 65.7%, achieved remission including complete remission and partial remission within 1 year after renal biopsy. Compared with a non-remission group, the levels of uPCR (6274.6 vs. 3235.6 mg/g, p = 0.007) and uACR (3433.6 vs. 1773.2 mg/g, p = 0.017) were significantly higher in remission group. The proportion of immunosuppressive therapy in the remission group was also higher (86.4% vs. 30.4%, p < 0.01). Compared with conservative treatment, patients with combined treatment with glucocorticoid and cyclophosphamide (CTX) or glucocorticoid and calcineurin inhibitor (CNIs) achieved higher remission rate (glucocorticoid plus cyclophosphamide vs. conservative treatment, 84.6% vs. 27.3%, p = 0.001; glucocorticoid plus calcineurin inhibitor vs. conservative treatment, 88.0% vs. 27.3%, p < 0.001). Further analysis showed that compared with patients who underwent conservative treatment, the proportion of males, the levels of uPCR, uACR, BUN, Scr, CysC and PLA2R antigen-positive staining rate in kidney biopsy were higher in those who underwent combined treatment with glucocorticoid and CTX, while the levels of eGFR, TP and ALB were lower (p < 0.05). In addition, patients who received combined treatment with glucocorticoid and CNIs had higher levels of uPCR, uACR, TC and lower levels of TP, ALB than those who received conservative treatment (p < 0.05). Moreover, there were no statistically significant differences in the 1-year progression rate in eGFR between the immunosuppressive treatment group and conservative treatment group (3.3 vs. 0.2 ml/min/1.73m(2), p = 0.852). Conclusions Most elderly patients diagnosed with IMN had multiple comorbidities, and the membranous Churg's stage II was most common. The glomerular PLA2R and IgG4 antigen deposition were frequently detected accompanied by glomerulosclerosis and severe tubulointerstitial injury. For high-risk elderly patients with severe proteinuria, early initial immunosuppressive therapy could achieve a higher urinary protein remission rate. Therefore, it is crucial for clinicians to balance the risks and benefits of immunosuppressive therapy based on clinical and pathological characteristics and develop individualized treatment regimens for elderly patients with IMN.

学科与关键词

关键词
Idiopathic membranous nephropathyelderlyclinical featuresrenal pathologyimmunosuppressive therapy
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
RENAL FAILURE
发表日期
2023-12-31
卷期
第 45 卷, 第 1 期
页码
2212081
DOI
10.1080/0886022X.2023.2212081
语言
ENGLISH
成果收录
SCIE

作者

  • L

    Liang, Jinxiu (第一作者)

    guangdong prov peoples hosp · southern med univ · 2

  • H

    Hao, Wenke

    guangdong prov peoples hosp · southern med univ

查看全部 9 位作者收起作者
  • X

    Xia, Fangxiao

    guangdong prov peoples hosp · southern med univ · 2

  • Z

    Zhao, Zhi

    guangdong prov peoples hosp · southern med univ

  • W

    Wu, Yanhua

    guangdong prov peoples hosp · southern med univ

  • Y

    Yu, Feng

    guangdong prov peoples hosp · southern med univ

  • H

    Hu, Wenxue

    guangdong prov peoples hosp · southern med univ

  • F

    Fang, Xiaowu

    guangdong prov peoples hosp · southern med univ

  • L

    Liu, Wei (通讯)

    guangdong prov peoples hosp · southern med univ · 2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417